Ciclosporin kinetics in children after stem cell transplantation

British Journal of Clinical Pharmacology

Volumn 66, Issue 4, 2008, Pages 539-545

  Willemze, A J ^a,b   Cremers, S C ^a   Schoemaker, R C ^c   Lankester, A C ^b   Den Hartigh, J ^a   Burggraaf, J ^c   Vossen, J M ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Paediatrics   (Netherlands)

^c CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

Author keywords

Bayesian; Children; Ciclosporin; Pharmacokinetics; Stem cell transplantation

Indexed keywords

CYCLOSPORIN A;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BODY WEIGHT; CHILD; CLINICAL ARTICLE; COMPARTMENT MODEL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

ADOLESCENT; AREA UNDER CURVE; BAYES THEOREM; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KINETICS; MALE; MODELS, BIOLOGICAL; SAMPLING STUDIES; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 51649129135     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03217.x     Document Type: Article

References (28)

1. Horwitz ME. Stem-cell transplantation for inherited immunodeficiency disorders. Pediatr Clin North Am 2000 47: 1371 87.
2. Sanders JE. Bone marrow transplantation for pediatric malignancies. Pediatr Clin North Am 1997 44: 1005 20.
3. Holler E. Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment. Best Pract Res Clin Haematol 2007 20: 281 94.
4. Fahr A. Cyclosporin clinical pharmacokinetics. Clin Pharmacokinet 1993 24: 472 95.
5. del Mar Fernández De Gatta M, Santos-Buelga D, Domínguez-Gil A, García MJ. Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations. Clin Pharmacokinet 2002 41: 115 35.
6. Schultz KR, Nevill TJ, Balshaw RF, Toze CL, Corr T, Currie CJ, Strong DK, Keown PA. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation. Bone Marrow Transplant 2000 26: 545 51.
7. Cooney GF, Habucky K, Hoppu K. Cyclosporin pharmacokinetics in paediatric transplant recipients. Clin Pharmacokinet 1997 32: 481 95.
8. Bader P, Kreyenberg H, Hoelle W, Dueckers G, Handgretinger R, Lang P, Kremens B, Dilloo D, Sykora KW, Schrappe M, Niemeyer C, Von Stackelberg A, Gruhn B, Henze G, Greil J, Niethammer D, Dietz K, Beck JF, Klingebiel T. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? J Clin Oncol 2004 22: 1696 705.
9. Bader P, Klingebiel T, Schaudt A, Theurer-Mainka U, Handgretinger R, Lang P, Niethammer D, Beck JF. Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia 1999 13: 2079 86.
10. Beal SL, Sheiner LB, Boeckmann AJ. NONMEM Users Guides, (1989-2006). Ellicot City, MD: Icon Development Solutions, 2006.
11. Lindbom L, Pihlgren P, Jonsson EN. PsN-Toolkit - a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed 2005 79: 241 57.
12. McDonald GB, Shulman HM, Sullivan KM, Spencer GD. Intestinal and hepatic complications of human bone marrow transplantation. Part II. Gastroenterology 1986 90: 770 84.
13. McDonald GB, Shulman HM, Sullivan KM, Spencer GD. Intestinal and hepatic complications of human bone marrow transplantation. Part I. Gastroenterology 1986 90: 460 77.
14. Schultz KR, Nevill TJ, Toze CL, Corr T, Currie C, Strong DK, Keown PA. The pharmacokinetics of oral cyclosporin A (Neoral) during the first month after bone marrow transplantation. Transplant Proc 1998 30: 1668 70.
15. Mochon M, Cooney G, Lum B, Caputo GC, Dunn S, Goldsmith B, Baluarte HJ, Polinsky MS, Kaiser BA. Pharmacokinetics of cyclosporine after renal transplant in children. J Clin Pharmacol 1996 36: 580 6.
16. Humbert H, Guest G, Said MB, Cabiac MD, Gagnadoux MF, Niaudet P, Broyer M. Steady-state pharmacokinetics of cyclosporine in renal transplant patients: does an influence of age or body weight exist? Transplant Proc 1994 26: 2791 7.
17. Duncan N, Craddock C. Optimizing the use of cyclosporin in allogeneic stem cell transplantation. Bone Marrow Transplant 2006 38: 169 74.
18. Lindholm A, Kahan BD. Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993 54: 205 18.
19. Citterio F. Evolution of the therapeutic drug monitoring of cyclosporine. Transplant Proc 2004 36: 420S 425S.
20. International Neoral Renal Transplantation Study Group. Cyclosporine microemulsion (Neoral) absorption profiling and sparse-sample predictors during the first 3 months after renal transplantation. Am J Transplant 2002 2: 148 56.
21. Kahan BD, Grevel J. Optimization of cyclosporine therapy in renal transplantation by a pharmacokinetic strategy. Transplantation 1988 46: 631 44.
22. Harmon WE, Sullivan EK. Cyclosporine dosing and its relationship to outcome in pediatric renal transplantation. Kidney Int Suppl 1993 43: S50 5.
23. Jain AB, Fung JJ, Tzakis AG, Venkataramanan R, Abu-Elmagd K, Alessiani M, Reyes J, Irish W, Warty V, Mehta S, Todo S, Starzl TE. Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. Transplant Proc 1991 23: 2763 6.
24. Choi JS, Lee SH, Chung SJ, Yoo KH, Sung KW, Koo HH. Assessment of converting from intravenous to oral administration of cyclosporin A in pediatric allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2006 38: 29 35.
25. Dupuis LL, Taylor T, Saunders EF. Disposition of two oral formulations of cyclosporine in pediatric patients receiving hematopoietic stem cell transplants. Pharmacotherapy 2006 26: 15 22.
26. Scholten EM, Rowshani AT, Cremers S, Bemelman FJ, Eikmans M, van Kan E, Mallat MJ, Florquin S, Surachno J, ten Berge IJ, Bajema IM, de Fijter JW. Untreated rejection in 6-month protocol biopsies is not associated with fibrosis in serial biopsies or with loss of graft function. J Am Soc Nephrol 2006 17: 2622 32.
27. Hogan WJ, Storb R. Use of cyclosporine in hematopoietic cell transplantation. Transplant Proc 2004 36: 367S 371S.
28. Locatelli F, Zecca M, Rondelli R, Bonetti F, Dini G, Prete A, Messina C, Uderzo C, Ripaldi M, Porta F, Giorgiani G, Giraldi E, Pession A. Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial. Blood 2000 95: 1572 9.